3-bromo-1-methyl-1H-pyrazole-5-carbaldehyde
- CAS NO.:1367843-92-2
- Empirical Formula: C5H5BrN2O
- Molecular Weight: 189.01
- Update Date: 2026-05-28 01:56:18
Properties of 3-bromo-1-methyl-1H-pyrazole-5-carbaldehyde
| Boiling point: | 280.4±20.0 °C(Predicted) |
| Density | 1.73±0.1 g/cm3(Predicted) |
| pka | -1.96±0.10(Predicted) |
Safety information for 3-bromo-1-methyl-1H-pyrazole-5-carbaldehyde
Computed Descriptors for 3-bromo-1-methyl-1H-pyrazole-5-carbaldehyde
3-bromo-1-methyl-1H-pyrazole-5-carbaldehyde manufacturer
SAKEM LLP
1Y
Phone:+91-9676889998
Whatsapp: +91-9676889998
product: 3-Bromo-1-methyl-1H-pyrazole-5-carbaldehyde 1367843-92-2 98%
New Products
Dibenzoyl-L-tartaric acid Anhydrous (Resolution Reagent) Cis-Tosylate Dibenzo[b,f][1,4]thiazepin-11(10H)-one 1,2,3,9-Tetrahydro-9-Methyl-4H-Carbazole-4-One 1-(4-methoxyphenyl)-4-(4-Nitrophenyl)Piperazine (IT-1) BOC Piperazine 1-Benzhydrylazetane-3-carbonitrile 8-oxa-1,3-diazaspiro[4.5]decane-2,4-dione (±)-amino(2-fluorophenyl)acetic acid 2-(2-Chlorophenyl)glycine AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 2'-Fluoroacetophenone METHANOL-D1(OD) TERTIARY BUTANOL-D9 N-ETHYL-D5-AMINE HYDROCHLORIDE BENZOIC ACID-D CHLOROFORM-D TOLUENE-D3 Trans,trans muconic acid HC Blue-16 4-Amino-2-chloro-6,7-dimethoxyquinazoline Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate 2,3-Dimethoxypyridine 1-(3-Chlorophenyl)piperazine hydrochlorideYou may like
-
1367843-92-2 3-Bromo-1-methyl-1H-pyrazole-5-carbaldehyde 99%View Details
1367843-92-2 -
1367843-92-2 99%View Details
1367843-92-2 -
3-Bromo-1-methyl-1H-pyrazole-5-carbaldehyde 1367843-92-2 98%View Details
1367843-92-2 -
3-Bromo-1-methyl-1H-pyrazole-5-carbaldehyde 98%View Details
1367843-92-2 -
Product InrtroductionView Details -
DGO24View Details -
DGO29View Details -
DGO32View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
